Výsledky vyhledávání - Sandra E. Dunn
- Zobrazuji výsledky 1 - 20 z 32
- Přejít na další stránku
-
1
-
2
-
3
-
4
MKNK1 is a YB-1 target gene responsible for imparting trastuzumab resistance and can be blocked by RSK inhibition Autor Arezoo Astanehe, Melanie Finkbeiner, Martin Krzywinski, Abbas Fotovati, Jaspreet Dhillon, Isabelle M. Berquin, Gordon B. Mills, Marco A. Marra, Sandra E. Dunn
Vydáno 2012Artigo -
5
-
6
Redefining prognostic factors for breast cancer: YB-1 is a stronger predictor of relapse and disease-specific survival than estrogen receptor or HER-2 across all tumor subtypes Autor Golareh Habibi, Samuel Leung, Jennifer Law, Karen A. Gelmon, Hamid Masoudi, Dmitry Turbin, Michaël Pollak, Torsten O. Nielsen, David G. Huntsman, Sandra E. Dunn
Vydáno 2008Artigo -
7
-
8
The transcriptional induction of PIK3CA in tumor cells is dependent on the oncoprotein Y-box binding protein-1 Autor Arezoo Astanehe, Melanie Finkbeiner, Payman Hojabrpour, Karen To, Abbas Fotovati, Ashleen Shadeo, Anna L. Stratford, Wan L. Lam, Isabelle M. Berquin, Vincent Duronio, Sandra E. Dunn
Vydáno 2009Artigo -
9
Y-box binding protein-1 serine 102 is a downstream target of p90 ribosomal S6 kinase in basal-like breast cancer cells Autor Anna L. Stratford, Christopher J. Fry, Curtis Desilets, Alastair Davies, Yong‐Yeon Cho, Yvonne Li, Zigang Dong, Isabelle M. Berquin, Philippe P. Roux, Sandra E. Dunn
Vydáno 2008Artigo -
10
Targeting YB-1 in HER-2 Overexpressing Breast Cancer Cells Induces Apoptosis via the mTOR/STAT3 Pathway and Suppresses Tumor Growth in Mice Autor Cathy Lee, Jaspreet Dhillon, Michelle Y.C. Wang, Yuanyuan Gao, Kaiji Hu, Eugene Park, Arezoo Astanehe, Mien‐Chie Hung, Peter Eirew, Connie J. Eaves, Sandra E. Dunn
Vydáno 2008Artigo -
11
Nuclear detection of Y-boxprotein-1 (YB-1) closely associates with progesterone receptor negativity and is a strong adverse survival factor in human breast cancer Autor Edgar Dahl, Abdelaziz En‐Nia, Frank Wiesmann, Renate Krings, Sonja Djudjaj, Elisabeth Breuer, Thomas J. Fuchs, Peter J. Wild, Arndt Hartmann, Sandra E. Dunn, Peter R. Mertens
Vydáno 2009Artigo -
12
YB-1 evokes susceptibility to cancer through cytokinesis failure, mitotic dysfunction and HER2 amplification Autor Alastair Davies, Irene Barrett, Mary Rose Pambid, Kaiji Hu, Anna L. Stratford, Spencer A. Freeman, Isabelle M. Berquin, Steven Pelech, P. Hieter, Christopher A. Maxwell, Sandra E. Dunn
Vydáno 2011Artigo -
13
YB-1 Expression and Phosphorylation Regulate Tumorigenicity and Invasiveness in Melanoma by Influencing EMT Autor Corinna Kosnopfel, Tobias Sinnberg, Birgit Sauer, Christian Busch, Heike Niessner, Anja Schmitt, Stephan Forchhammer, Cornelia Grimmel, Peter R. Mertens, Stephan Hailfinger, Sandra E. Dunn, Claus Garbe, Birgit Schittek
Vydáno 2018Artigo -
14
Celecoxib analogues disrupt Akt signaling, which is commonly activated in primary breast tumours Autor Jill E. Kucab, Cathy Lee, Ching‐Shih Chen, Jiuxiang Zhu, C. Blake Gilks, Maggie C.U. Cheang, David G. Huntsman, Erika Yorida, Joanne T. Emerman, Michaël Pollak, Sandra E. Dunn
Vydáno 2005Artigo -
15
Luteolin is a novel p90 ribosomal S6 kinase (RSK) inhibitor that suppresses Notch4 signaling by blocking the activation of Y-box binding protein-1 (YB-1) Autor Kristen M. Reipas, Jennifer Law, Nicole Couto, Sumaiya Islam, Yvonne Li, Huifang Li, Artem Cherkasov, Karen Jung, Amarpal S. Cheema, Steven J.M. Jones, John A. Hassell, Sandra E. Dunn
Vydáno 2013Artigo -
16
Disulfiram, a drug widely used to control alcoholism, suppresses self-renewal of glioblastoma and overrides resistance to temozolomide Autor Joanna Triscott, Cathy Lee, Kaiji Hu, Abbas Fotovati, Rachel Berns, Mary Rose Pambid, Margaret Luk, Richard E. Kast, Esther Kong, Eric Toyota, Stephen Yip, Brian Toyota, Sandra E. Dunn
Vydáno 2012Artigo -
17
Disruption of the Y-Box Binding Protein-1 Results in Suppression of the Epidermal Growth Factor Receptor and HER-2 Autor Joyce C. Wu, Cathy Lee, Daniel Yokom, Helen Jiang, Maggie C.U. Cheang, Erika Yorida, Dmitry Turbin, Isabelle M. Berquin, Peter R. Mertens, Thomas Iftner, C. Blake Gilks, Sandra E. Dunn
Vydáno 2006Artigo -
18
Targeting p90 Ribosomal S6 Kinase Eliminates Tumor-Initiating Cells by Inactivating Y-Box Binding Protein-1 in Triple-Negative Breast Cancers Autor Anna L. Stratford, Kristen M. Reipas, Kaiji Hu, Abbas Fotovati, Rachel Brough, Jessica Frankum, Mandeep Takhar, Peter H. Watson, Alan Ashworth, Christopher J. Lord, Annette Lasham, Cristin G. Print, Sandra E. Dunn
Vydáno 2012Artigo -
19
Preferential Dependence of Breast Cancer Cells versus Normal Cells on Integrin-Linked Kinase for Protein Kinase B/Akt Activation and Cell Survival Autor Armelle A. Troussard, Paul C. McDonald, Elizabeth D. Wederell, Nasrin M. Mawji, Nolan R. Filipenko, Karen A. Gelmon, Jill E. Kucab, Sandra E. Dunn, Joanne T. Emerman, Marcel B. Bally, Shoukat Dedhar
Vydáno 2006Artigo -
20
Polo-Like Kinase 1 Inhibition Kills Glioblastoma Multiforme Brain Tumor Cells in Part Through Loss of SOX2 and Delays Tumor Progression in Mice Autor Cathy Lee, Abbas Fotovati, Joanna Triscott, James Chen, Chitra Venugopal, Ash Singhal, Christopher Dunham, J. M. Munro Kerr, Maïté Verreault, Stephen Yip, Hiroaki Wakimoto, Chris Jones, Aarthi Jayanthan, Aru Narendran, Sheila K. Singh, Sandra E. Dunn
Vydáno 2012Artigo
Vyhledávací nástroje:
Související témata
Biology
Cancer research
Cancer
Gene
Genetics
Cell biology
Medicine
Internal medicine
Biochemistry
Breast cancer
Kinase
Molecular biology
Oncology
Signal transduction
Protein kinase B
Phosphorylation
Cancer stem cell
Cell
Cell cycle
Chemistry
Carcinogenesis
Medulloblastoma
PI3K/AKT/mTOR pathway
Bioinformatics
CD44
Cancer cell
Cell culture
Gene silencing
P70-S6 Kinase 1
Stem cell